Jacobs Levy Equity Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-252,330
Closed -$262K 951
2024
Q3
$262K Sell
252,330
-748,727
-75% -$779K ﹤0.01% 902
2024
Q2
$1.73M Buy
+1,001,057
New +$1.73M 0.01% 628
2024
Q1
Sell
-1,614,278
Closed -$5.38M 952
2023
Q4
$5.38M Buy
1,614,278
+1,425,343
+754% +$4.75M 0.03% 413
2023
Q3
$707K Buy
+188,935
New +$707K ﹤0.01% 737
2023
Q2
Sell
-519,505
Closed -$3.55M 985
2023
Q1
$3.55M Sell
519,505
-243,897
-32% -$1.67M 0.02% 468
2022
Q4
$6.05M Buy
763,402
+191,555
+33% +$1.52M 0.04% 361
2022
Q3
$5.5M Sell
571,847
-316,737
-36% -$3.04M 0.04% 376
2022
Q2
$6.43M Buy
+888,584
New +$6.43M 0.05% 373
2021
Q4
Sell
-141,652
Closed -$2.28M 984
2021
Q3
$2.28M Buy
141,652
+3,101
+2% +$49.8K 0.02% 589
2021
Q2
$1.92M Sell
138,551
-626,638
-82% -$8.67M 0.01% 608
2021
Q1
$11.2M Buy
765,189
+515,055
+206% +$7.52M 0.09% 271
2020
Q4
$4.35M Buy
250,134
+100,489
+67% +$1.75M 0.04% 423
2020
Q3
$2.74M Buy
149,645
+37,560
+34% +$689K 0.03% 461
2020
Q2
$2M Sell
112,085
-43,641
-28% -$779K 0.02% 532
2020
Q1
$2.53M Sell
155,726
-111,424
-42% -$1.81M 0.03% 430
2019
Q4
$4.81M Buy
267,150
+109,019
+69% +$1.96M 0.05% 382
2019
Q3
$3.2M Buy
158,131
+20,540
+15% +$416K 0.04% 414
2019
Q2
$3.04M Buy
137,591
+43,005
+45% +$950K 0.04% 443
2019
Q1
$1.29M Buy
94,586
+44,100
+87% +$601K 0.02% 608
2018
Q4
$457K Sell
50,486
-31,725
-39% -$287K 0.01% 745
2018
Q3
$1.36M Buy
82,211
+15,155
+23% +$250K 0.02% 593
2018
Q2
$939K Buy
67,056
+33,550
+100% +$470K 0.01% 679
2018
Q1
$370K Buy
+33,506
New +$370K 0.01% 828
2016
Q3
Sell
-12,800
Closed -$216K 1025
2016
Q2
$216K Buy
+12,800
New +$216K ﹤0.01% 992